KL-6
Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma
9
MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis
7
Rheumatoid Arthritis with High Serum KL 6 Complicating Malignant Tumor: Two Case Reports
5
Original Article Association between serum Krebs von den Lungen-6 (KL-6), Carcinoma antigen 15-3 (CA15-3), and connective tissue disease-related interstitial pneumonia (CTD-ILD)
11
Original Article SP-D, KL-6, and HTI-56 levels in children with mycoplasma pneumoniae pneumonia
7
The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D
7
KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome
7
Serum KL 6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
8
Original Article Clinical value of serum KL-6 for lung diseases in patients with polymyositis and dermatomyositis
5
Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients
9
Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease
11
Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis
10
KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome
8
Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis
8
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case–control study
9
Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias
9
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report
5
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
11
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
10
Preoperative Serum Krebs Von Den Lungen 6 and Surfactant Protein D Levels in Non Small Cell Lung Cancer Patients with Interstitial Pneumonia
7